Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Consultant of vascular and endovascular surgery
Dr Konstantinos Stavroulakis is a Consultant Vascular and Endovascular Surgeon at St. Franziskus Hospital, Münster, Germany. He trained at the University of Crete Medical School until 2009. He moved to Germany in 2012 and became a Trainee of Surgery and Vascular Surgery at the Paracelsus Clinic Marl, Germany. He achieved his Postgraduate (Dr.med) qualification in March 2016 from the Westphälische… View more
Job title: Consultant Interventional Radiologist
Dr Jason Wilkins trained in medicine at St. Edmund Hall Oxford and was appointed as a Consultant Radiologist at King’s College Hospital in 2002. He is currently clinical lead for interventional radiology and musculoskeletal imaging. His specialist interests in intervention and musculoskeletal imaging include endovascular therapy, tumour ablation, venous and dialysis access and urolological… View more
Author(s): Alfonso Ielasi Added: 1 year ago
This video features Dr Alfonso Ielasi (IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, IT) presenting a dynamic poster focused on the 2-Year Follow-up of a Hybrid Strategy for Diffuse Coronary Artery Disease (CAD).He highlights the challenging nature of de novo diffuse coronary artery disease (CAD) in interventional cardiology, where limited treatment options exist beyond stent implantation.To… View more
Author(s): Ling Tao Added: 8 months ago
EuroPCR 2024 — Investigator, Dr Ling Tao joins us to discuss the findings from the CAGEFREE II trial.Compared to drug-eluting stents, drug-coated balloons are associated with faster vessel healing and reduced thrombotic burden, therefore patients treated with DCBs require a less intensive antiplatelet therapy. CAGEFREE II investigated the effectiveness and safety of a tailored one-month DAPT… View more
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 4 months ago
Which trials will have the greatest impact at TCT 2024?Get a head start on the biggest cardiovascular breakthroughs of TCT 24! Leading experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) offer an exclusive preview of the most anticipated late-breaking studies set to be unveiled at TCT Conference 2024. Discover their in-depth analysis of these studies and… View more
Author(s): Robert Yeh Added: 1 year ago
TCT 23 - In this short online interview, we are joined by Dr Robert Yeh (Beth Israel Deaconess Medical Center, US) to discuss the findings of the AGENT IDE trial (NCT04647253), sponsored by Boston Scientific. AGENT IDE is a prospective, 2:1 randomized multicenter trial that aimed to compare the AGENT paclitaxel-coated balloon to plain-old balloon angioplasty (POBA) with a commercially available… View more
Author(s): Roberto Garbo , , , et al Start date: Jun 03, 2024
Join us for a transformative broadcast, chaired by Dr Tomáš Kovárník (Charles University, Prague, CZ), showcasing the latest advancements in CTO PCI procedures with state-of-the-art technology.Investigate the possibility of shortening stent lengths with precision physiology guidance, featuring Dr Mohamed Ayoub's (University Heart Center NRW, Bad Oeynhausen, DE) presentationExplore the combination… View more
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 5 months ago
ESC Congress 24 – Day 4 of the ESC Congress 2024 was filled with hot line and late-breaking data poised to influence cardiovascular practice.Interventional experts DrMirvat Alasnagand DrKhaled Al-Shaibi(King Fahd Armed Forces Hospital, SA) joined us to review and distil the key messages from the latest data presented at the last of the biggest cardiovascular event of 2024.Day 4 Highlights:00:19… View more
Author(s): Ulf Teichgräber Added: 3 months ago
TCT Conference 2024 - Safety and efficacy outcomes of the trial shows that percutaneous transluminal angioplasty (PTA) with the sirolimus drug coated balloon (DCB) in patients with femoropopliteal artery disease was/was not noninferior to PTA with the paclitaxel DCB.Prof Ulf Teichgräber joins us onsite at TCT Conference to discuss the findings from the sirolimus- vs. paclitaxel-coated balloon… View more
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
Join Prof Nicolas Van Mieghem and Dr Joost Daemen, interventional experts from the Thoraxcenter at Erasmus MC in Rotterdam, as they provide a comprehensive preview of the late-breaking trials and studies that will be presented at EuroPCR 2023. In this dynamic episode, they offer valuable insights into the latest developments in interventional clinical and research science. Studies include:… View more